Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 14 (Search time: 0.003 seconds).
Issue DateTitleAuthor(s)
2013Outcomes of sunitinib therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) with poor risk featuresBARROSO-SOUSA, Romualdo; MUNHOZ, Rodrigo Ramella; FONSECA, Leonardo Gomes; FEDE, Angelo Bezerra de Sousa; LINCK, Rudinei Diogo Marques; MONIZ, Camila Motta Venchiarutti; MAK, Milena Perez; SOUZA, Ciro Eduardo; HOFF, Paulo M.; DZIK, Carlos
2013Should all patients (pts) with advanced biliary cancers receive first-line treatment with cisplatin and gemcitabine (GC)?MIRANDA, Vanessa Costa; DIB-FARIA, Luiza; BRAGHIROLI, Maria Ignez Freitas Melro; SABBAGA, Jorge; SARAGIOTTO, Daniel Fernandes; CASTRO, Gilberto; HOFF, Paulo M.; RIECHELMANN, Rachel
2012Expression of ERCC1 protein (excision repair cross complementing group 1) in patients with invasive carcinoma of the uterine cervix (CC) undergoing definitive chemoradiation (CR)CAIRES, Inacelli Queiroz de Souza; CAIRES-LIMA, Rafael; COLOMBO, Renata; RAMOS, Clarissa C. A.; MACHADO, Karime Kalil; SIQUEIRA, Sheila Aparecida Coelho; CARVALHO, Heloisa de Andrade; FUKUSHIMA, Julia Tizue; ADRA, Thais Rodrigues; HOFF, Paulo M.; ESTEVEZ-DIZ, Maria Del Pilar
2018Pharmacokinetic (PK) and exposure-response (ER) analysis of pertuzumab (P) in patients (pts) with HER2-positive metastatic gastroesophageal junction and gastric cancer (mGEJC/GC).KIRSCHBROWN, Whitney Paige; WANG, Bei; NIJEM, Ihsan; OHTSU, Atsushi; HOFF, Paulo M.; SHAH, Manish A.
2013Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2 positive advanced or metastatic gastric (A/MGC), esophageal (EAC), or gastroesophageal (GEJ) adenocarcinoma: The LOGiC trial.HECHT, J. Randolph; BANG, Yung-Jue; QIN, Shukui; CHUNG, Hyun-Chul; XU, Jian-Ming; PARK, Joon Oh; JEZIORSKI, Krzysztof; SHPARYK, Yaroslav; HOFF, Paulo M.; SOBRERO, Alberto F.; SALMAN, Pamela; LI, Jin; PROTSENKO, Svetlana; BUYSE, Marc E.; AFENJAR, Karen; KANEKO, Tomomi; KEMNER, Allison; SANTILLANA, Sergio; PRESS, Michael F.; SLAMON, Dennis J.
2013Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial.HECHT, J. Randolph; BANG, Yung-Jue; QIN, Shukui; CHUNG, Hyun-Chul; XU, Jian-Ming; PARK, Joon Oh; JEZIORSKI, Krzysztof; SHPARYK, Yaroslav; HOFF, Paulo M.; SOBRERO, Alberto F.; SALMAN, Pamela; LI, Jin; PROTSENKO, Svetlana; BUYSE, Marc E.; AFENJAR, Karen; KANEKO, Tomomi; KEMNER, Allison; SANTILLANA, Sergio; PRESS, Michael F.; SLAMON, Dennis J.
2013Cancer patients with ECOG-PS higher than 1: Who are those who benefit of palliative chemotherapy?CAIRES-LIMA, Rafael; PROTASIO, Bruno Mendonca; CAIRES, Inacelli Queiroz de Souza; ROCHA, Lucila Soares Da Silva; OLIVEIRA, Julia Andrade De; GUERRA, Raquel Bezerra; MAK, Milena Perez; HOFF, Paulo M.; CASTRO, Gilberto
2013Clinical characteristics at diagnosis of patients who survive more than 5 years after diagnosis of metastatic colorectal cancer (mCRC).ABRAHAO, Manuel Cruz; SANTOS, Joao Paulo Velloso Medrado; PAVAN, Thayse; HOFF, Paulo M.; KATZ, Artur; SABBAGA, Jorge; AZEVEDO, Fernanda; FREITAS, Daniel; SARAGIOTTO, Daniel F.; COSTA, Frederico
2012Feasibility of two schedules of weekly paclitaxel as (neo)adjuvant treatment for patients (PTS) with HER2-negative breast cancer (BC) in the Brazilian community settingSANTANA, Iuri Amorim; OLIVEIRA, Julia Andrade De; AMARAL, Alan Alves; TESTA, Laura; LANDEIRO, Luciana Garcia; COSTA, Romulo Leopoldo de Paula; HAJIME, Marcelo; FERRARI, Marcela Simonis Martins; PETRY, Vanessa; COHN, Daniela J. B. Heinemann; HOFF, Paulo M.; MANO, Max S.
2012Metronomic chemotherapy (MC) in the neoadjuvant setting: Results of two parallel feasibility trials in patients (pts) with HER2 positive (HER2+) and negative (HER2-) locally advanced breast cancer (LABC) (Traq-Me and TAME)PETRY, Vanessa; LEAL, Alessandro; ARAI, Roberto J.; MARINHO, Simone; PAIVA, Marcelo; PIATO, Jose R.; ROSA, Marcio; HOFF, Paulo M.; MANO, Max S.